药康生物 (688046.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(药康生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 454,564,476.69295,864,533.76140,304,915.96516,547,576.88386,281,384.05250,366,972.03116,124,141.67
 营业收入(元) 454,564,476.69295,864,533.76140,304,915.96516,547,576.88386,281,384.05250,366,972.03116,124,141.67
二、营业总成本(元) 349,773,222.18230,524,550.76109,276,292.77392,092,874.07285,523,134.45177,563,423.0283,981,505.90
 营业成本(元) 140,293,735.5793,237,008.8043,072,255.75147,818,345.85103,259,110.2161,794,013.1327,054,499.11
 研发费用(元) 75,305,788.4550,458,176.6824,232,493.7882,928,357.0561,531,906.4338,610,778.4917,759,796.98
 营业税金及附加(元) 1,188,398.33801,474.88405,376.771,721,223.53892,422.60732,671.61142,687.26
 销售费用(元) 57,014,813.8238,597,203.4918,071,131.9976,338,958.2358,026,248.1536,375,080.5517,154,094.62
 管理费用(元) 87,139,085.3055,514,904.2526,690,358.6998,425,570.2673,657,357.9747,222,648.5022,278,634.43
 财务费用(元) -11,168,599.29-8,084,217.32-3,195,324.21-15,139,580.85-11,843,910.91-7,171,769.25-408,206.50
  其中:利息费用(元) 1,822,164.441,073,108.43392,688.30495,527.80213,820.03355,200.55272,391.02
  其中:利息收入(元) 12,630,183.988,160,524.913,854,335.5714,243,311.0510,526,416.256,801,039.58738,258.34
三、其他经营收益
 加:公允价值变动收益(元) 1,109,712.531,577,600.292,340,391.98-45,743.528,724,263.102,843,135.90158,227.67
 加:投资收益(元) 9,681,802.466,148,422.18673,483.109,488,039.114,711,399.893,413,991.861,579,170.91
  其中:对联营企业和合营企业的投资收益(元) 459,599.89502,614.84296,183.71-1,541,502.03-289,354.54-188,019.0680,783.99
 资产处置收益(元) -17,191.38-17,191.38--100,893.44-100,893.44-95,906.71-26,184.06
 资产减值损失(元) -13,863,343.31-10,008,150.79-5,757,684.61-15,284,413.51-10,087,730.09-6,035,538.58-2,612,299.18
 信用减值损失(元) -9,774,303.06-7,160,719.53-2,989,981.22-6,862,363.67-4,869,853.19-5,283,248.84-4,409,701.10
 其他收益(元) 32,140,354.5425,805,378.997,217,250.6862,304,080.6446,436,322.3625,680,827.438,147,436.76
 营业利润平衡项目(元) --0.01-0.01---
四、营业利润(元) 124,068,286.2981,685,322.7532,512,083.12173,953,408.43145,571,758.2393,326,810.0734,979,286.77
 加:营业外收入(元) 85,081.832.451.022.861.710.240.13
 减:营业外支出(元) 113,998.0310,056.15-271,825.08271,825.0820,792.07792.07
 利润总额平衡项目(元) 0.01------
五、利润总额(元) 124,039,370.1081,675,269.0532,512,084.14173,681,586.21145,299,934.8693,306,018.2434,978,494.83
 减:所得税费用(元) 6,325,363.164,106,798.051,461,879.119,037,952.0417,173,809.6511,671,005.444,653,989.24
六、净利润(元) 117,714,006.9477,568,471.0031,050,205.03164,643,634.18128,126,125.2181,635,012.8030,324,505.59
(一)按经营持续性分类
  持续经营净利润(元) 117,714,006.9477,568,471.0031,050,205.03164,643,634.18128,126,125.2181,635,012.8030,324,505.59
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 117,714,006.9477,568,471.0031,050,205.03164,643,634.18128,126,125.2181,635,012.8030,324,505.59
 扣除非经常性损益后的净利润(元) 81,655,473.8349,525,097.4822,257,363.18102,056,252.7877,599,408.6654,417,436.1221,746,200.00
七、每股收益
 一、基本每股收益(元) 0.290.190.080.420.330.220.08
 二、稀释每股收益(元) 0.290.190.080.420.330.220.08
八、其他综合收益(元) 398,820.96487,281.13-176,070.19641,063.02690,397.68119,801.07-39,665.03
 归属于母公司股东的其他综合收益(元) 398,820.96487,281.13-176,070.19641,063.02690,397.68119,801.07-39,665.03
九、综合收益总额(元) 118,112,827.9078,055,752.1330,874,134.84165,284,697.20128,816,522.8981,754,813.8730,284,840.56
 归属于母公司所有者的综合收益总额(元) 118,112,827.9078,055,752.1330,874,134.84165,284,697.20128,816,522.8981,754,813.8730,284,840.56
公告日期 2023-10-282023-08-312023-04-282023-04-202022-10-312022-08-202022-04-22
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院